Hasan Basri Çakmak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hasan Basri Çakmak has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Nurullah Cagil
Lokman Hekim University
18 shared publications Yasin Toklu
Department of Ophthalmology, Ankara Atatürk Education and Research Hospital, Yıldırım Beyazıt University, Ankara, Turkey
15 shared publicationsŞaban Şimşek
9 shared publications- Huseyin Simavli
Harvard Medical School, Boston, Massachusetts; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
7 shared publications - Mehmet Erol Can
Department of Ophthalmology, Bursa City Hospital, Bursa, Turkey
6 shared publications Saban Simsek
Ophthalmology Department, Ankara Atatürk Training and Research Hospital, Ankara, Turkey
6 shared publications
Latest Publications
- Open Access
- 28 November 2023
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Comparison of Dry Eye Findings in Diabetes Mellitus Patients with and without Diabetic Foot
Purpose: To compare dry eye findings in diabetes mellitus patients with and without diabetic foot. Methods: Diabetes mellitus patients with and without diabetic foot were included in this controlled cross-sectional study. Tear break-up time (BUT) and Schirmer test results of each participant were noted. Ocular Surface Disease Index (OSDI) questionnaire was administered to each participant. Results: There were 48 diabetic patients in the study; half of them had diabetic foot (n=24). The patients with and without diabetic foot were similar in age and sex distribution. The median levels of BUT (4.0 [3.0 – 6.0] seconds for the right eye, 4.5 [3.0 – 6.5] seconds for the left eye in patients with diabetic foot) (4.0 [3.8 – 6.2] seconds for the right eye, 5.0 [3.8 – 5.2] second for the left eye in patients without diabetic foot) and Schirmer’s test (7.0 [5.0 – 17.0] mm for the right eye, 11.0 [6.8 – 17.0] mm for the left eye in patients with diabetic foot) (11.0 [7.0 – 15.8] mm for the right eye, 14.5 [6.5 – 18.5] mm for the left eye in patients without diabetic foot) were similar in both groups of patients. The scores of OSDI were similar in patients with diabetic foot (22.7 [13.5 – 36.2]) and without diabetic foot (28.4 [13.6 – 41.5]) (p=0.749). Conclusion: The Schirmer test, BUT test, and OSDI score were lower in patients with diabetic foot, but they were not statistically significant. In future studies, peripheral neuropathy examination and corneal confocal microscopy may be beneficial when evaluating dry eye parameters in this group of patients.
- 28 November 2023
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Open AccessComparison of Dry Eye Findings in Diabetes Mellitus Patients with and without Diabetic Foot
Purpose: To compare dry eye findings in diabetes mellitus patients with and without diabetic foot. Methods: Diabetes mellitus patients with and without diabetic foot were included in this controlled cross-sectional study. Tear break-up time (BUT) and Schirmer test results of each participant were noted. Ocular Surface Disease Index (OSDI) questionnaire was administered to each participant. Results: There were 48 diabetic patients in the study; half of them had diabetic foot (n=24). The patients with and without diabetic foot were similar in age and sex distribution. The median levels of BUT (4.0 [3.0 – 6.0] seconds for the right eye, 4.5 [3.0 – 6.5] seconds for the left eye in patients with diabetic foot) (4.0 [3.8 – 6.2] seconds for the right eye, 5.0 [3.8 – 5.2] second for the left eye in patients without diabetic foot) and Schirmer’s test (7.0 [5.0 – 17.0] mm for the right eye, 11.0 [6.8 – 17.0] mm for the left eye in patients with diabetic foot) (11.0 [7.0 – 15.8] mm for the right eye, 14.5 [6.5 – 18.5] mm for the left eye in patients without diabetic foot) were similar in both groups of patients. The scores of OSDI were similar in patients with diabetic foot (22.7 [13.5 – 36.2]) and without diabetic foot (28.4 [13.6 – 41.5]) (p=0.749). Conclusion: The Schirmer test, BUT test, and OSDI score were lower in patients with diabetic foot, but they were not statistically significant. In future studies, peripheral neuropathy examination and corneal confocal microscopy may be beneficial when evaluating dry eye parameters in this group of patients.
- 29 August 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (5) , 1851-1861
The evaluation of the risk factors for capsular complications in phacoemulsification
To determine and quantify the risk factors for disruption of lens capsule integrity during phacoemulsification.
- 29 August 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (5) , 1851-1861
The evaluation of the risk factors for capsular complications in phacoemulsification
To determine and quantify the risk factors for disruption of lens capsule integrity during phacoemulsification.
- 1 August 2017
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 87, 152-161
Cyclotorsion measurement using scleral blood vessels
- 1 August 2017
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 87, 152-161
Cyclotorsion measurement using scleral blood vessels
- Open Access
- 16 June 2017
- Published by Springer Nature in Eye
- Vol. 31 (11) , 1606-1612
A novel graft option after pterygium excision: platelet-rich fibrin for conjunctivoplasty
To compare the surgical results, complications, and recurrence rates of primary pterygium excision with conjunctival autografts (CA) vs platelet-rich fibrin (PRF) grafts. A total of 35 eyes of 35 patients with primary pterygium were included in the study. The patients underwent excision of pterygium followed by closure of the bare sclera by CA (group 1, n=20) vs PRF grafts (group 2, n=15). The PRF was generated from the patients’ own whole-blood sample by centrifugation and pressing. The surgery times, intra/postoperative complications, recurrence rates of pterygium, and changes in visual acuity (VA) were evaluated and compared within groups. The mean follow-up period was 14.3±6.5 months (6–24 months). The mean preoperative and postoperative VAs were same (20/25) (P=0.204). The mean surgery time was shorter in group 2 (22.1±1.9 min) compared to group 1 (33.8±7.8 min) (P=0.001). The recurrence was observed only in one (6.6%) case of group 2, while none of the cases showed recurrence in group 1. Graft loss was observed in 2 (10%) cases in group 1, and 1 (6.6%) case in group 2. No other intra/postoperative complications such as tear in the graft, excessive bleeding, scleral necrosis, graft necrosis, pannus formation, or symblepharon occurred in both groups. This preliminary study showed encouraging results of the application of PRF for conjuntivoplasty after pterygium excision. The use of PRF in pterygium surgery is a simple, easily applicable, and a promising method with low rates of recurrence and complications.
- 16 June 2017
- Published by Springer Nature in Eye
- Vol. 31 (11) , 1606-1612
Open AccessA novel graft option after pterygium excision: platelet-rich fibrin for conjunctivoplasty
To compare the surgical results, complications, and recurrence rates of primary pterygium excision with conjunctival autografts (CA) vs platelet-rich fibrin (PRF) grafts. A total of 35 eyes of 35 patients with primary pterygium were included in the study. The patients underwent excision of pterygium followed by closure of the bare sclera by CA (group 1, n=20) vs PRF grafts (group 2, n=15). The PRF was generated from the patients’ own whole-blood sample by centrifugation and pressing. The surgery times, intra/postoperative complications, recurrence rates of pterygium, and changes in visual acuity (VA) were evaluated and compared within groups. The mean follow-up period was 14.3±6.5 months (6–24 months). The mean preoperative and postoperative VAs were same (20/25) (P=0.204). The mean surgery time was shorter in group 2 (22.1±1.9 min) compared to group 1 (33.8±7.8 min) (P=0.001). The recurrence was observed only in one (6.6%) case of group 2, while none of the cases showed recurrence in group 1. Graft loss was observed in 2 (10%) cases in group 1, and 1 (6.6%) case in group 2. No other intra/postoperative complications such as tear in the graft, excessive bleeding, scleral necrosis, graft necrosis, pannus formation, or symblepharon occurred in both groups. This preliminary study showed encouraging results of the application of PRF for conjuntivoplasty after pterygium excision. The use of PRF in pterygium surgery is a simple, easily applicable, and a promising method with low rates of recurrence and complications.
- 2 March 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (2) , 459-467
Effect of cataract surgery in patients with neovascular age-related macular degeneration: further evidence from disciform scars
To evaluate the effect of cataract surgery on disease activation and visual outcomes in neovascular age-related macular degeneration (AMD).
- 2 March 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (2) , 459-467
Effect of cataract surgery in patients with neovascular age-related macular degeneration: further evidence from disciform scars
To evaluate the effect of cataract surgery on disease activation and visual outcomes in neovascular age-related macular degeneration (AMD).
- 1 January 2017
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 48 (1) , 10-17
Choroidal Thickness in Childhood Obesity
BACKGROUND AND OBJECTIVE: To evaluate the effects of obesity on choroidal thickness (CT) in childhood. PATIENTS AND METHODS: Forty-four patients with obesity (study group) and 42 healthy children (control group) were enrolled in the study. Subjects underwent a complete ocular examination. The mean CT was measured by enhanced depth imaging optical coherence tomography (EDI-OCT). Body mass index (BMI) was calculated. RESULTS: Mean BMI value was 31.8 ± 1.9 in the study group and 19.8 ± 4.4 in the control group. The mean subfoveal CT value 385.77 µm ± 6.09 µm in the study group and 348.43 µm ± 73.21 µm in the control group. There was a significant difference between the study and control groups with regard to subfoveal CT ( P = .017). Subfoveal CT and BMI were positively correlated (r = 0.288; P = .004). CONCLUSIONS: CT increases in childhood obesity. Findings revealed that adiposity causes a significant increase in CT, and it may be related to ocular complications. [ Ophthalmic Surg Lasers Imaging Retina. 2017;48:10–17.]
- 1 January 2017
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 48 (1) , 10-17
Choroidal Thickness in Childhood Obesity
BACKGROUND AND OBJECTIVE: To evaluate the effects of obesity on choroidal thickness (CT) in childhood. PATIENTS AND METHODS: Forty-four patients with obesity (study group) and 42 healthy children (control group) were enrolled in the study. Subjects underwent a complete ocular examination. The mean CT was measured by enhanced depth imaging optical coherence tomography (EDI-OCT). Body mass index (BMI) was calculated. RESULTS: Mean BMI value was 31.8 ± 1.9 in the study group and 19.8 ± 4.4 in the control group. The mean subfoveal CT value 385.77 µm ± 6.09 µm in the study group and 348.43 µm ± 73.21 µm in the control group. There was a significant difference between the study and control groups with regard to subfoveal CT ( P = .017). Subfoveal CT and BMI were positively correlated (r = 0.288; P = .004). CONCLUSIONS: CT increases in childhood obesity. Findings revealed that adiposity causes a significant increase in CT, and it may be related to ocular complications. [ Ophthalmic Surg Lasers Imaging Retina. 2017;48:10–17.]
- 1 January 2017
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 47 (1) , 40-46
Intravitreal PRN ranibizumab treatment for macular edemadue to branch retinal vein occlusion
Background/aim: To evaluate the effect of intravitreal pro re nata (PRN) ranibizumab treatment from the start on the best-corrected visual acuity (BCVA) and the central retinal thickness (CRT) in macular edema (ME) due to branch retinal vein occlusion (BRVO). Materials and methods: Patients with ME secondary to BRVO, who were treated on a PRN basis after a single intravitreal ranibizumab injection, were retrospectively evaluated. The main outcome measures were changes in BCVA and CRT as measured by optical coherence tomography. Results: The number of injections over 6 months was 2.43 +/- 1.16. The mean BCVA of the patients was 0.84 +/- 0.10 logMAR at baseline and 0.41 +/- 0.06 at the 6th month (P < 0.001). Mean BCVA of the ischemic BRVO group was 1.06 +/- 0.68 logMAR at baseline and 0.44 +/- 0.30 logMAR at the 6th month (P < 0.05). Similarly, the mean BCVA of the nonischemic BRVO group was 0.77 +/- 0.53 logMAR at baseline and 0.41 +/- 0.36 logMAR at the 6th month (P < 0.05). Between groups, there was no significant difference in mean BCVA at any examination. Conclusion: Intravitreal ranibizumab is a safe and effective treatment option for ME due to ischemic and nonischemic BRVO using PRN from the start.
- 1 January 2017
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 47 (1) , 40-46
Intravitreal PRN ranibizumab treatment for macular edemadue to branch retinal vein occlusion
Background/aim: To evaluate the effect of intravitreal pro re nata (PRN) ranibizumab treatment from the start on the best-corrected visual acuity (BCVA) and the central retinal thickness (CRT) in macular edema (ME) due to branch retinal vein occlusion (BRVO). Materials and methods: Patients with ME secondary to BRVO, who were treated on a PRN basis after a single intravitreal ranibizumab injection, were retrospectively evaluated. The main outcome measures were changes in BCVA and CRT as measured by optical coherence tomography. Results: The number of injections over 6 months was 2.43 +/- 1.16. The mean BCVA of the patients was 0.84 +/- 0.10 logMAR at baseline and 0.41 +/- 0.06 at the 6th month (P < 0.001). Mean BCVA of the ischemic BRVO group was 1.06 +/- 0.68 logMAR at baseline and 0.44 +/- 0.30 logMAR at the 6th month (P < 0.05). Similarly, the mean BCVA of the nonischemic BRVO group was 0.77 +/- 0.53 logMAR at baseline and 0.41 +/- 0.36 logMAR at the 6th month (P < 0.05). Between groups, there was no significant difference in mean BCVA at any examination. Conclusion: Intravitreal ranibizumab is a safe and effective treatment option for ME due to ischemic and nonischemic BRVO using PRN from the start.
- 1 January 2017
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in Turkish Journal of Electrical Engineering and Computer Sciences
- Vol. 25 (2) , 1223-1237
Assessing the importance of features for detection of hard exudates in retinal images
- 1 January 2017
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in Turkish Journal of Electrical Engineering and Computer Sciences
- Vol. 25 (2) , 1223-1237
Assessing the importance of features for detection of hard exudates in retinal images
- 1 December 2016
- Published by Wolters Kluwer Health in Cornea
- Vol. 35 (12) , 1503-1507
Factors Influencing Progression of Keratoconus 2 Years After Corneal Collagen Cross-Linking in Pediatric Patients
To assess the preoperative patient characteristics that may predict outcomes of keratoconus 2 years after corneal collagen cross-linking (CXL) in pediatric patients with keratoconus. This retrospective study included 72 eyes of 52 consecutive patients with keratoconus under the age of 18 with 2-year follow-up after CXL. Subgroup analysis and cutoff values were determined as per age ( 0.05 for all variables). In pediatric patients with keratoconus, cone location and the baseline thinnest corneal thickness seem to affect the success rate of CXL treatment after 2-year follow-up.
- 1 December 2016
- Published by Wolters Kluwer Health in Cornea
- Vol. 35 (12) , 1503-1507
Factors Influencing Progression of Keratoconus 2 Years After Corneal Collagen Cross-Linking in Pediatric Patients
To assess the preoperative patient characteristics that may predict outcomes of keratoconus 2 years after corneal collagen cross-linking (CXL) in pediatric patients with keratoconus. This retrospective study included 72 eyes of 52 consecutive patients with keratoconus under the age of 18 with 2-year follow-up after CXL. Subgroup analysis and cutoff values were determined as per age ( 0.05 for all variables). In pediatric patients with keratoconus, cone location and the baseline thinnest corneal thickness seem to affect the success rate of CXL treatment after 2-year follow-up.
- 6 September 2016
- Published by Journal of the Faculty of Engineering and Architecture of Gazi University in Gazi Üniversitesi Mühendislik-Mimarlık Fakültesi Dergisi
- Vol. 31 (3)
GÖRÜNTÜ BÖLÜTLEME ve GÖRÜNTÜ BENZETİMİ YÖNTEMLERİ YARDIMI ile HASTALIĞIN TEŞHİS ve TEDAVİ SONRASI SÜREÇLERİNİN DESTEKLENMESİ: KERATOKONUS ÖRNEĞİ
- 6 September 2016
- Published by Journal of the Faculty of Engineering and Architecture of Gazi University in Gazi Üniversitesi Mühendislik-Mimarlık Fakültesi Dergisi
- Vol. 31 (3)
GÖRÜNTÜ BÖLÜTLEME ve GÖRÜNTÜ BENZETİMİ YÖNTEMLERİ YARDIMI ile HASTALIĞIN TEŞHİS ve TEDAVİ SONRASI SÜREÇLERİNİN DESTEKLENMESİ: KERATOKONUS ÖRNEĞİ